admin

Making payments on student loans can feel like a daunting task, especially if you’re struggling financially. If you’re looking for a way to reduce your monthly payment and improve your cash flow, refinancing is one strategy. However, before you decide to refinance, it’s important to consider your personal situation and determine whether it makes sense
Student loan rates are currently some of the lowest we’ve seen in history. However, while the rates might look attractive, there are still some things to consider before you take on student loan debt in this volatile economic climate. The interest rate for undergraduate federal Stafford loans issued between July 1, 2021, and July 1,
[Editor’s note: “Prosper From Apple’s Major Upcoming Product Launch” was previously published in August 2022. It has since been updated to include the most relevant information available.] When Apple (AAPL) unveiled the first iPhone back in 2007, the late, great Steve Jobs implied that the iPod-lookalike with Blackberry-level functionality was a revolutionary product that would
SoFi Technologies (NASDAQ:SOFI) stock has been a disappointment for investors. From the outset, the neo-banking firm was supposed to disrupt the American financial sector. Yet, that vision hasn’t become a reality in the 2020s. Long-term SOFI stockholders are still struggling to break even. Tight central bank monetary policy certainly won’t make things easier for SoFi Technologies. Besides,
Exchange-traded funds (ETFs) hold a collection of securities—such as stocks—that often track an underlying index. While they are similar to mutual funds in some ways, ETFs are different in that they are listed on exchanges and can be traded throughout the day like traditional stocks. In recent years, ETFs have become immensely popular with investors
After some challenging months in 2022, investors of California-headquartered workforce-management software company Asana (NYSE:ASAN) finally got some good news. For one thing, the company posted results indicating sizable big-client spending boosts. On top of that, a Meta Platforms (NASDAQ:META) co-founder (known as Facebook when he co-founded it) just took a large position in Asana. All in
Monetary policy will be in the spotlight this week, with the Federal Reserve, the Bank of England (BoE), and the Bank of Japan (BoJ) all scheduled to hold policy meetings and decide on interest rates. Sweden’s central bank could be the first to act, with an interest rate decision to hike rates by 75 basis points (bps) expected tomorrow. The Fed is
Take a look at some of the biggest movers in the premarket: AutoZone (AZO) – AutoZone gained 3.9% in premarket action after the auto parts retailer reported better-than-expected profit and revenue for its latest quarter. AutoZone’s same-store sales rose 6.2% compared to a year ago, twice what analysts had predicted amid continued strength in its
The best nuclear energy stocks represent companies that have a future as world seems to be fast approaching an energy crisis. Oil prices soared during the better part of the year, while natural gas prices are rising on fears over supply constraints heading into the winter. Some experts claim that nuclear energy is perhaps critical
Most countries rely on migrant workers, defined as someone who has migrated from their home country or another country for employment purposes. Migrant workers can be found in nearly every country in the world. The life of a migrant can be difficult, and many lack unions, social connections, and lack the language skills of the
Lucas Walton Builders Vision, the investing and philanthropy platform of billionaire Lukas Walton, has shifted its $1 billion endowment into what it calls “impact investments,” leading a broader shift in family offices to connect their investing and giving. Chicago-based Builders Vision will announce today that its Builders Initiative Foundation has moved 90% of its endowment
Anti-aging stocks have not proven immune to poor market conditions that have plagued the broader biotech industry. The biotech industry remains hampered by the same bleak economic conditions as those affecting growth companies. As a result, the Nasdaq Biotechnology Index and SPDR S&P Biotech ETF (NYSEARCA:XBI) have fallen 16.5% and 23.5%, year to date (YTD),